undruggable Ewing onco-chimera
Ewing sarcoma lethality
onco-chimera protein
Ewing sarcoma patients
onco-chimeras
onco-chimera degradation
transcription factor onco-proteins
mice Ewing sarcomagenesis
transcription factor chimeric onco-protein
novel platform
therapeutic point of view
genetic platform
project
Development of efficient therapeutic strategies
development of new therapies
childhood cancer
conventional pharmacological point of view
ideal target
past years
brain tumors
tremendous success
juvenile form of cancer
leukemia
balanced chromosomal translocation
fine-tuning
exclusive hallmark of tumor cells
common types of pediatric
fusion
force
disease
low incidence
lymphoma
mortality rate
structure convenient targeting pockets
innovative ex
Identification of druggable targets
mechanisms
cases
pathways
sarcomas treatment
EWS
FLI1 genes
initial oncogenic event
dogma
tumorigenic process
following steps
Generation
Characterization
approach